Oncology in midlife and beyond

Climacteric

Volumn 16, Issue 5, 2013, Pages 522-535

  Gompel, A ^a   Baber, R J ^b   De Villiers, T J ^c   Huang, K E ^d   Santen, R J ^e   Shah, D ^f   Villaseca, P ^g   Shapiro, S ^h  

^a HÔTEL DIEU   (France)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF STELLENBOSCH   (South Africa)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^f Gynaecworld   (India)

^g PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^h UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Breast Cancer; Cervical Cancer; Colorectal Cancer; Endometrial Cancer; Incidence; Lung Cancer; Menopause; Mortality; Ovarian Cancer

Indexed keywords

AFRICA SOUTH OF THE SAHARA; ALCOHOL CONSUMPTION; ASIA; ATTITUDE TO HEALTH; AUSTRALIA AND NEW ZEALAND; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CAUSE OF DEATH; COLORECTAL CANCER; ENDOMETRIUM CANCER; FEMALE; HEALTH CARE ACCESS; HEALTH CARE PLANNING; HUMAN; LIFE EXPECTANCY; LUNG CANCER; NORTH AMERICA; OVARY CANCER; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; SMOKING; SOCIAL STATUS; SOUTH AMERICA; SOUTHERN EUROPE; UTERINE CERVIX CANCER; WEIGHT REDUCTION; WESTERN EUROPE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; DIET; ENDOMETRIAL NEOPLASMS; ETHNIC GROUPS; FEMALE; HEALTH PROMOTION; HUMANS; INCOME; LIFE EXPECTANCY; LIFE STYLE; LUNG NEOPLASMS; MALE; MENOPAUSE; MIDDLE AGED; NEOPLASMS; OBESITY; OVARIAN NEOPLASMS; UTERINE CERVICAL NEOPLASMS;

EID: 84884497099     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2013.823539     Document Type: Review

References (81)

1. Anderson BO, Cazap E, El Saghir NS, et al. Optimisation of breast cancer management in low-resource and middle-resource countries: Executive summary of the BreasThealth Global Initiative consensus, 2010. Lancet Oncol 2011; 12: 387-98
2. Regional mortality information system. Regional Health Observatory, Pan American Health Observatory (PAHO), 2011. http:// ais.paho.org/phip/viz/mort- chapters-en.asp
3. Http://www.healthmetricsandevaluation.org/gbd/visualizations/ gbd-2010-patterns-broad-cause-group
4. Lozano R, Naghavi M, Forman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095-128
5. Thttp://globocan.iarc.fr/ Ferlay J, Shin H R, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010
6. World Health Organization, mortality database. h ttp://www. who.int/healthinfo/statistics/mortality-rawdata/en/index.html
7. Forouzanfar M H, Forman K J, Delossantos A M, et a l. Breast and cervical cancer in 187 countries between 1980 and 2010: A systematic analysis. Lancet 2011; 378: 1461-84
8. Molina J R, Yang P, Cassivi S D, Schild S E, Adjei A A. Non-small cell lung cancer: Epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 2008; 83: 584-94
9. Long B, Liu FW, Bristow RE. D isparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States. Gynecol Oncol 2013 May 23; Epub ahead of print
10. Chia KS, Reilly M, Tan CS, et al. Profound changes in breast cancer incidence may refl ect changes into a Westernized lifestyle: A comparative population-based study in Singapore and Sweden. Int J Cancer 2005; 113: 302-6
11. Lin C H, Chen Y C, Chiang C J, et a l. The emerging epidemic of estrogen-related cancers in young women in a developing Asian country. Int J Cancer 2012; 130: 2629-37
12. Khokhar A. Breast cancer in India: Where do we stand and where do we go? Asian Pac J Cancer Prev 2012; 13: 4861-6
13. Huo D, Ikpatt F, Khramtsov A, et al. Population differences in breast cancer: Survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol 2009; 27: 4515-21
14. Yip C H, Taib N A, Mohamed I. Epidemiology of breast cancer in Malaysia. Asian Pac J Cancer Prev 2006; 7: 369-4
15. Su Y, Zheng Y, Zheng W, et al. Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: A population-based cohort study. BMC Cancer 2011; 11: 292
16. Ly M, Antoine M, Andre F, et a l. [ Breast cancer in Sub-Saharan African women: Review]. Bull Cancer 2011; 98: 797-806
17. Tay SK, Ngan HY, Chu TY, Cheung AN, Tay EH. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan. Vaccine 2008; 26(Suppl 12): M60-70
18. Domingo E J, Noviani R, Noor M R, et a l. Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam. Vaccine 2008; 265: M71-9
19. Bailie R. The epidemiological basis for cervical cancer screening. S Afr Med J 1995; 85: 8-10
20. Department of Health, Medical Research Council, OrcMacro. South African Demographic and Health Survey 2003. Pretoria: Department of Health, 2007
21. Travis W D, Brambilla E, Noquchi M, et a l. International Association for the Study of Lung Cancer/American Thoracic Society/ European Respiratory Society International Multidisciplinary Classification of lung adenocarcinoma. J Thorac Oncol 2011; 6: 244-85
22. Lee P N, Forey B A. Indirectly estimated absolute lung cancer mortality rates by smoking status and histological type based on a systematic review. BMC Cancer 2013; 13: 189
23. Yano T, HJaro A, Shikada Y, et a l. Non-small cell lung cancer in never smokers as a representative non-smoking-Associated lung cancer ': Epidemiology and clinical features. Int J Clin Oncol 2011; 16: 287-93
24. Haggar F A, Boushey R P. Colorectal cancer epidemiology: Incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 2009; 22: 191-7
25. Garborg K, Holme O, Loberg M, et al. Current status of screening for colorectal cancer. Ann Oncol 2013; 24: 1963-72
26. Geier A S, Wellmann J, Wellmann I, et a l. Cancer detection rates following enrolment in a disease management programme for type 2 diabetes. Diabetologia 2013 May 31; Epub ahead of print
27. Zendehdel K, Nyran O, Ostenson C G, et a l. Cancer incidence in patients with type 1 diabetes mellitus: A population-based cohort study in Sweden. J Natl Cancer Inst 2003; 95: 1797-800
28. Torres M L, Weaver A L, Kumar S, et a l. Risk factors for developing endometrial cancer after benign endometrial sampling. Obstet Gynecol 2012; 120: 998-1004
29. Chornokur G, Amankwah E K, Schildkraut J M, Phelan CM. Global ovarian cancer health disparities. Gynecol Oncol 2013 ; 129: 258-64
30. Lim S S, Vos T, Flaxman A D, et a l. Acomparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2224-60
31. Gao CM, Ding JH, Li SP, et al. Active and passive smoking, and alcohol drinking and breast cancer risk in chinese women. Asian Pac J Cancer Prev 2013; 14: 993-6
32. Golzarand M, Mirmiran P, Jessri M, et al. Dietary trends in the Middle East and North Africa: An ecological study (1961 to 2007). Public Health Nutr 2012; 15: 1835-44
33. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012; 307: 491-7
34. Garg C, Khan SA, Ansari SH, Garg M. Prevalence of obesity in Indian women. Obes Rev 2010; 11: 105-8
35. Gupta R, Deedwania P C, Achari V, et a l. Normotension, prehypertension, and hypertension in urban middle-class subjects in India: Prevalence, awareness, treatment, and control. Am J Hypertens 2013; 26: 83-94
36. Nidhi R, Padmalatha V, Nagarathna R, Amritanshu R. Prevalence of polycystic ovarian syndrome in Indian adolescents. J Pediatr Adolesc Gynecol 2011; 24: 223-7
37. Chang Y, Schechter C B, van Ravesteyn N T, et a l. Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortality. Breast Cancer Res Treat 2012; 136 : 823-35
38. Pichard C, Plu-Bureau G, Neves-E-Castro M, Gompel A. Insulin resistance, obesity and breast cancer risk. Maturitas 2008; 60 : 19-30
39. Ogundiran TO, Huo D, Adenipekun A, et al. Body fat distribution and breast cancer risk: Findings from the Nigerian breast cancer study. Cancer Causes Control 2012; 23: 565-74
40. Protani M, Coory M, Martin JH. Effect of obesity on survival of women with breast cancer: Systematic review and meta-Analysis. Breast Cancer Res Treat 2010; 123: 627-35
41. Larsson S, Wolk A. Obesity and colon and rectal cancer risk: A meta-Analysis of prospective studies. Am J Clin Nutr 2007; 86 : 556-65
42. Pischon T, Lahmann PH, Boeing H, et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2006; 98: 920-31
43. Morrison DS, Parr CL, Lam TH, et a l. Behavioural and metabolic risk factors for mortality from colon and rectum cancer: Analysis of data from the Asia-pacific cohort studies collaboration. Asian Pac J Cancer Prev 2013; 14: 1083-7
44. Arem H, Park Y, Pelser C, et a l. Prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients. J Natl Cancer Inst 2013; 105: 342-9
45. Suzuki R, Ye W, Rylander-Rudqvist T, et al. Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: A prospective cohort study. J Natl Cancer Inst 2005; 97: 1601-8
46. Minami Y, Tsubono Y, Nishino Y, et al. The increase of female breast cancer incidence in Japan: Emergence of birth cohort effect. Int J Cancer 2004; 108: 901-6
47. Minami Y, Nishino Y, Tsubono Y, et al. Increase of colon and rectal cancer incidence rates in Japan: Trends in incidence rates in Miyagi Prefecture, 1959-1997. J Epidemiol 2006 ; 16: 240-8
48. Mizoue T, Tanaka K, Tsuji I, et al. Alcohol drinking and colorectal cancer risk: An evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2006; 36: 582-97
49. Tavani A, La Vecchia C. Coffee, decaffeinated coffee, tea and cancer of the colon and rectum: A review of epidemiological studies, 1990-2003. Cancer Causes Control 2004; 15: 743-57
50. Li G, Ma D, Zhang Y, et al. Coffee consumption and risk of colorectal cancer: A meta-Analysis of observational studies. Public Health Nutr 2013; 16: 346-57
51. Calle EE, Frumkin H, Henley SJ, et al. Organochlorines and breast cancer risk. CA Cancer J Clin 2002; 52: 301-9
52. Bjerkaas E, Parajuli R, Weiderpass E, et al. Smoking duration before first childbirth: An emerging risk factor for breast cancer? Results from 302,865 Norwegian women. Cancer Causes Control 2013 ;24: 1347-56
53. Kaushal M, Mishra A K, Sharma J, et a l. Genomic alterations in breast cancer patients in betel quid and non betel quid chewers. PLoS One 2012; 7: E43789
54. Brinton L A, Felix A S. Menopausal hormone therapy and risk of endometrial cancer. J Steroid Biochem Mol Biol 2013 May 13 ; Epub ahead of print
55. Wartko P, Sherman ME, Yang HP, et al. Recent changes in endometrial cancer trends among menopausal-Age US women. Cancer Epidemiol 2013; 37: 374-7
56. Rice MS, Murphy MA, Tworoger SS. T ubal ligation, hysterectomy and ovarian cancer: A meta-Analysis. J Ovarian Res 2012; 5: 13
57. Melin A S, Lundholm C, Malki N, et a l. Hormonal and surgical treatments for endometriosis and risk of epithelial ovarian cance r. Acta Obstet Gynecol Scand 2013; 92: 546-54
58. Rossouw JE, Anderson G L, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-33
59. Lobo RA. Where are we 10 years after the Women's Health Initiative? J Clin Endocrinol Metab 2013; 98: 1771-80
60. Fenton A, Panay N. The Women's Health Initiative-A decade of progress. Climacteric 2012; 15: 205-94
61. Tehard B, Friedenreich CM, Oppert JM, Clavel-Chapelon F. Effect of physical activity on women at increased risk of breast cancer: Results from the E3N cohort study. Cancer Epidemiol Biomarkers Prev 2006; 15: 57-64
62. Yang HP, Anderson WF, Rosenberg PS, et al. Ovarian cancer incidence trends in relation to changing patterns of menopausal hormone therapy use in the United States. J Clin Oncol 2013; 31: 2146-51
63. Gompel A, Santen R J. Hormone therapy and breast cancer risk 10 years after the WHI. Climacteric 2012; 15: 241-9
64. Anderson G L, Chlebowski R T, Araqaki A K, et a l. Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: Extended follow-up of the Women's Health Initiative randomised placebo-controlled trial. Lancet Oncol 2012; 13: 476-86
65. Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with differenThormone replacement therapies: Results from the E3N cohort study. Breast Cancer Res Treat 2008; 107: 103-11
66. Chlebowski RT, Anderson GL, Manson JE, et al. Lung cancer among postmenopausal women treated with estrogen alone in the Women's Health Initiative randomized trial. J Natl Cancer Inst 2010; 102: 1413-21
67. Chlebowski RT, Schwartz AG, Wakelee H, et al. Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): A post-hoc analysis of a randomised controlled trial. Lancet 2009; 374: 1243-51
68. Brinton LA, Gierach GL, Andaya A, et al. Reproductive and hormonal factors and lung cancer risk in the NIH-AARP Diet and Health Study cohort. Cancer Epidemiol Biomarkers Prev 2011; 20: 900-11
69. Gallagher L G, Rosenblatt K A, Ray R M, et a l. Reproductive factors and risk of lung cancer in female textile workers in Shanghai, China. Cancer Causes Control 2013; 24: 1305-14
70. Http://www.cancerscreening.gov.au
71. Http://www.nsu.govt.nz
72. WHO 2008-2013 Action Plan for the Global Strategy for the Prevention and Control of Noncommunicable Diseases. Geneva: World Health Organization, 2008
73. World Health Organization. C ervical cancer screening in developing countries: Report of a WHO consultation. Geneva: World Health Organization, 2002
74. Hoffman M, Cooper D, Carara H, et al. Limited Pap screening associated with reduced risk of cervical cancer in South Africa. Int J Epidemiol 2003; 32: 573-7
75. Hewitson P, Glasziou P, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev 2007 (1): DD001216
76. Hippisley-Cox J, Coupland C. Symptoms and risk factors to identify women with suspected cancer in primary care: Derivation and validation of an algorithm. Br J Gen Pract 2013; 63: 11-21
77. World Cancer Research Fund/American Institute for Cancer Research. Policy and action for cancer prevention. In Food, Nutrition and Physical Activity: A Global Perspective. Washington DC: AICR, 2009
78. Poli A, Marangoni F, Avogaro A, et al. Moderate alcohol use and health: A consensus document. Nutr Metab Cardiovasc Dis 2013; 23: 487-504
79. Fair AM, Montgomery K. Energy balance, physical activity, and cancer risk. Methods Mol Biol 2009; 472: 57-88
80. Steindorf K, Ritte R, Eomois PP, et al. Physical activity and risk of breast cancer overall and by hormone receptor status: The European prospective investigation into cancer and nutrition. Int J Cancer 2013; 132: 1667-78
81. Romaguera D, Vergnaud AC, Peeters PH, et al. Is concordance with World Cancer Research Fund/American Institute for Cancer Research guidelines for cancer prevention related to subsequent risk of cancer? Results from the EPIC study. Am J Clin Nutr 2012; 96: 150-63